Investigational Program
BridgePoint Medical has taken a comprehensive product development approach that includes pre-clinical testing to demonstrate basic product safety and functionality, a First-in Man (FIM) clinical product evaluation, and a CTO-focused Investigational Device Exemption (IDE) study entitled Facilitated Antegrade Steering Technique in Chronic Total Occlusions, or FAST-CTOs. This approach has included a high degree of collaboration with CTO-PCI clinical experts from around the world to help ensure the focus is always on clinical performance. Located on the left of this page are links that provide information from the different stages of product development.